What to watch with LDL and blood sugar?

Monitoring LDL cholesterol and blood sugar is essential for cardiovascular and metabolic health. The provided context lacks specific data on these biomarkers, instead covering DNA tests for fat metabolism genes (FADS, APOA2, PPARA) and microbiome analyses. These tests have small effect sizes and are not clinically actionable. For LDL, watch total LDL, non-HDL cholesterol, and possibly particle size – standard targets are <100 mg/dL for high-risk individuals. For blood sugar, monitor fasting glucose (<100 mg/dL), HbA1c (<5.7%), and postprandial levels. Genetic variants may slightly influence individual responses to fats or carbohydrates, but evidence is weak (mechanistic, small studies). A balanced diet rich in unsaturated fats, fiber, and regular exercise outweighs any genetic insight. Do not overinterpret direct-to-consumer tests; they are marketing tools, not medical diagnostics. Evidence grade: practice/experience, as no context-specific studies are provided.